Star51 Capital

About

Portfolio · 1

UltraSight

UltraSight develops AI-driven software for real-time guidance in cardiac ultrasound imaging.

1 round $24.0M committed Latest: 2026-09

Q&A

What is Star51 Capital's investment focus?

Star51 Capital is an operator-led venture capital firm that invests in early and growth-stage companies at the intersection of medical technology (Medtech) and artificial intelligence (AI).

Which sectors does Star51 Capital prioritize for investments?

Star51 Capital primarily focuses on Health Tech & Life Sciences and Artificial Intelligence sectors.

What investment stages does Star51 Capital target?

Star51 Capital targets both Early Stage and Growth Stage companies.

Where is Star51 Capital headquartered?

Star51 Capital is headquartered in New York, United States.

Who are the Founding Managing Partners of Star51 Capital?

The Founding Managing Partners of Star51 Capital are Adam Rosenwach and Tal Wenderow.

What is Star51 Capital's investment thesis?

Star51 Capital's thesis is to combine strategic capital with operator networks to support portfolio companies through clinical validation, regulatory clearance, commercialization, and scaling, focusing on areas where AI can improve clinical outcomes or economics within Medtech.

What is the name of Star51 Capital's inaugural fund?

Star51 Capital's inaugural fund is named "Inaugural Medtech and AI Venture Fund," launched in 2026.

Does Star51 Capital have a specific geographic focus for investments?

Yes, Star51 Capital prefers to invest in companies located in the US, Europe, and the Middle East, including Israel.